Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Dr. Lal PathLabs Ltd (DLPA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,390.00 +59.00    +2.53%
26/04 - Closed. Currency in INR ( Disclaimer )
  • Volume: 17,355
  • Bid/Ask: 2,380.00 / 2,387.05
  • Day's Range: 2,325.00 - 2,399.50
Type:  Equity
Market:  India
ISIN:  INE600L01024 
S/N:  LALPATHLAB
Dr. Lal PathLabs 2,390.00 +59.00 +2.53%

DLPA Income Statement & Profits

 
Assess the Dr. Lal PathLabs Ltd income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 5389 6013 5410 4909.82
Revenue 5389 6013 5410 4909.82
Other Revenue, Total - - - -
Cost of Revenue, Total 2160 2278 2178 2666.58
Gross Profit 3229 3735 3232 2243.24
Total Operating Expenses 4343 4594 4299 4125.29
Selling/General/Admin. Expenses, Total 777 852 745 1481.57
Research & Development - - - -
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating -70 -78 -80 -90.3
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 1476 1542 1456 67.44
Operating Income 1046 1419 1111 784.53
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - 72.28
Other, Net -113 -103 -64 -119.02
Net Income Before Taxes 1159 1522 1175 831.27
Provision for Income Taxes 337 415 339 262.5
Net Income After Taxes 822 1107 836 568.77
Minority Interest - 339 - 332.47
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 813 1093 826 566.48
Total Extraordinary Items - - - -
Net Income 813 1093 826 566.48
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 813 1093 826 566.48
Dilution Adjustment - - - -0.33
Diluted Net Income 813 1093 826 566.81
Diluted Weighted Average Shares 83.3 83.31 83.18 83.14
Diluted EPS Excluding Extraordinary Items 9.76 13.12 9.93 6.82
DPS - Common Stock Primary Issue 12 - 6 6
Diluted Normalized EPS 8.59 11.25 8.71 5.63
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DLPA Price Commentary

Write your thoughts about Dr. Lal PathLabs Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rupesh Surve
Rupesh Surve Dec 15, 2021 4:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
omicron effect profit to pharma co
naseer khazi
naseer khazi Dec 14, 2021 17:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tomorrow gap up 3550
Mohammad Mursalin
Mohammad Mursalin Aug 08, 2021 13:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hi I am new on the app can anyone help me to buy the share from Dr LAL pathlabs
Dmo Janjgir
Dmo Janjgir Dec 23, 2020 12:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a true multibagger for 2030
Dharmaraj Paul
Dharmaraj Paul May 14, 2020 9:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the stock is at inflection point.It may chart a new trendline on the upside and thereon longterm uptrend possible as it has held base from 1300 to 1650 for more than six months.
Dharmaraj Paul
Dharmaraj Paul Nov 14, 2019 6:59
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now it has caught the fancy of some investors ...given short term profit they will fly away...and that only would make the counter more resistant to downwards movement...thus giving away to strong hand.
Dharmaraj Paul
Dharmaraj Paul Oct 02, 2019 12:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a few stock like this never comes in frontline. a multibagger in hindsight.
Dnyandeo Kale
Dnyandeo Kale Feb 24, 2019 12:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
money Maker
Dharmaraj Paul
Dharmaraj Paul Nov 06, 2018 16:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
taking out shares from public.
Balkrishna Bhatt
Balkrishna Bhatt Sep 08, 2018 7:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
highly volatile
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email